CSOFT Health Sciences announced its appointment of Vladimir Misik, PhD as Vice President of Global Clinical Strategy.
The Pistoia Alliance announced Becky Upton,PhD as its first female president.
Chris Schoonmaker has joined PHASTAR as Chief Operations Officer.
eClinical Solutions named Venu Mallarapu as their new Vice President of Strategy and Global Operations.
Saama Technologies, LLC announced that Vivek Sharma has joined the company as Chief Executive Officer.
Walgreens announced the hiring of the following: Kendal Whitlock as Head of Digital Optimization, Real World Evidence Clinical Trials; John Campbell as Head of Decentralized Clinical Trials; Liam Wood as Head of Product, Clinical Trials; and Adam Samson as Head of Clinical Delivery Operations, Clinical Trials.
Clario announced that Christopher Fikry, MD has begun his tenure as CEO.
Noel Alaka joined COTA, Inc. as Vice President of Life Sciences.
MMS Holdings has been selected by MAPS Public Benefit Corporation (MAPS PBC) as its CRO for the development of a New Drug Application for MDMA-assisted therapy for posttraumatic stress disorder.
HeartcoR Solutions announced it has relocated from Algonquin, IL to Schaumburg, IL.
Sharp has expanded its clinical services offering at its Heerenveen facility in the Netherlands.
SGS’s Quay Pharma will open its new pharmaceutical development and clinical manufacturing facility in Hudson, NH.
Emmes researchers contributed to a successful AIDS Malignancy Consortium study and the results were published in the New England Journal of Medicine.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.